Johan Clukers, Maarten Lanclus, Dennis Belmans, Cedric Van Holsbeke, Wilfried De Backer, Dharshan Vummidi, Paul Cronin, Ben R Lavon, Jan De Backer and Dinesh Khanna
Vanhaverbeke K, Slaats M, Al-Nejar M, et al.
In March 2020 Fluidda’s medical device called Broncholab was introduced in the USA. It is a diagnostic support tool to detect and to to improve therapy of lung diseases based on FRI technology. Broncholab will initially... View Article
Dr. Muhunthan Thillai is a pulmonologist at Cambridge University, specialized in pulmonary fibrosis; and co-founder and CEO of Qur8, an imaging platform for analyzing large clinical sets of data. He is... View Article
In the recently published “Fluidda’s Magazine on FRI”, Dr. Firdaus Hoesein, radiologist at the University Medical Centre Utrecht, was interviewed about his experiences with FRI and his expectations for the use... View Article
In the recently published “Fluidda’s Magazine on FRI”, Dr. Langton, pulmonologist at the University of Melbourne specialized in bronchial thermoplasty treatment, was interviewed about his experiences with FRI and his... View Article
In the latest issue of the magazine Pharma Focus Asia, dedicated to precision medicine and personalizing health outcomes, the founders of Fluidda were interviewed. In this interview titled: “ Functional... View Article
In a recent publication in the European Respiratory Journal (ERJ) by Morris et al. a retrospective analysis was performed of chest CT scans of 313 COVID-19 positive and 195 COVID-19 negative patients seeking acute medical care. From... View Article
We are pleased to announce that CT scans of more than 5000 COVID-19 patients from all corners of the world have been analyzed with Fluidda’s recently developed BVX parameter! The BVX parameter... View Article
Metered dose inhalers (MDI’s) are one of the most common device types for delivering inhaled therapies. However, there are several technical challenges in development and drug delivery of these medications.... View Article